Salud financiera de hoja de balance de GMO AD Partners

Salud financiera controles de criterios 6/6

GMO AD Partners tiene un patrimonio de los accionistas total de ¥5.2B y una deuda total de ¥0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son ¥10.4B y ¥5.2B respectivamente.

Información clave

Ratio deuda-patrimonio

JP¥0

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	JP¥5.11b
Patrimonio	JP¥5.16b
Total pasivo	JP¥5.24b
Activos totales	JP¥10.40b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Risks Still Elevated At These Prices As GMO AD Partners Inc. (TSE:4784) Shares Dive 33%

Aug 10

Does GMO AD Partners' (TYO:4784) Share Price Gain of 58% Match Its Business Performance?

Feb 25

Three Things You Should Check Before Buying GMO AD Partners Inc. (TYO:4784) For Its Dividend

Feb 04

Is Weakness In GMO AD Partners Inc. (TYO:4784) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Jan 14

Three Days Left To Buy GMO AD Partners Inc. (TYO:4784) Before The Ex-Dividend Date

Dec 24

Should You Be Impressed By GMO AD Partners' (TYO:4784) Returns on Capital?

Dec 15

Should GMO AD Partners (TYO:4784) Be Disappointed With Their 77% Profit?

Nov 24

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (¥8.6B) de 4784 superan a sus pasivos a corto plazo (¥4.8B).

Pasivo a largo plazo: Los activos a corto plazo de 4784 (¥8.6B) superan a sus pasivos a largo plazo (¥441.0M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 4784 está libre de deudas.

Reducción de la deuda: 4784 no tenía deudas hace 5 años.

Cobertura de la deuda: 4784 no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: 4784 no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.

Salud financiera de hoja de balance de GMO AD Partners

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

GMO AD Partners Inc. to Report Q3, 2024 Results on Nov 06, 2024

New major risk - Financial data availability

Second quarter 2024 earnings released: JP¥9.06 loss per share (vs JP¥0.43 loss in 2Q 2023)

Risks Still Elevated At These Prices As GMO AD Partners Inc. (TSE:4784) Shares Dive 33%

GMO AD Partners Inc.'s (TSE:4784) 27% Price Boost Is Out Of Tune With Revenues

New minor risk - Share price stability

GMO AD Partners Inc. to Report Q2, 2024 Results on Aug 06, 2024

First quarter 2024 earnings released: EPS: JP¥3.78 (vs JP¥7.02 in 1Q 2023)

Full year 2023 earnings released: EPS: JP¥2.48 (vs JP¥24.93 in FY 2022)

GMO AD Partners Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: JP¥2.48 (vs JP¥24.93 in FY 2022)

GMO AD Partners Inc., Annual General Meeting, Mar 19, 2024

Upcoming dividend of JP¥2.40 per share at 3.8% yield

GMO AD Partners Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024

New minor risk - Profit margin trend

Third quarter 2023 earnings released: JP¥3.72 loss per share (vs JP¥7.68 profit in 3Q 2022)

GMO AD Partners Inc. to Report Q3, 2023 Results on Nov 06, 2023

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: JP¥0.43 loss per share (vs JP¥6.16 profit in 2Q 2022)

GMO AD Partners Inc. to Report Q2, 2023 Results on Aug 03, 2023

First quarter 2023 earnings released: EPS: JP¥7.02 (vs JP¥12.44 in 1Q 2022)

Now 20% undervalued

Full year 2022 earnings released: EPS: JP¥24.93 (vs JP¥20.51 in FY 2021)

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Full year 2022 earnings released: EPS: JP¥24.93 (vs JP¥20.51 in FY 2021)

GMO AD Partners Inc., Annual General Meeting, Mar 23, 2023

Upcoming dividend of JP¥11.00 per share

GMO AD Partners Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023

Third quarter 2022 earnings released: EPS: JP¥7.68 (vs JP¥1.31 in 3Q 2021)

GMO AD Partners Inc. to Report Q3, 2022 Results on Nov 07, 2022

Second quarter 2022 earnings released: EPS: JP¥6.16 (vs JP¥5.85 in 2Q 2021)

Investor sentiment improved over the past week

GMO AD Partners Inc. to Report Q2, 2022 Results on Aug 04, 2022

First quarter 2022 earnings released: EPS: JP¥12.44 (vs JP¥10.34 in 1Q 2021)

GMO AD Partners Inc. to Report Q1, 2022 Results on May 09, 2022

GMO AD Partners Inc., Annual General Meeting, Mar 19, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥9.80 per share

Third quarter 2021 earnings released: EPS JP¥1.31 (vs JP¥4.92 in 3Q 2020)

GMO AD Partners Inc. (JASDAQ:4784) announces an Equity Buyback for 350,000 shares, representing 2.18% for ¥195.3 million.

Second quarter 2021 earnings released: EPS JP¥5.85 (vs JP¥3.61 in 2Q 2020)

First quarter 2021 earnings released: EPS JP¥10.34 (vs JP¥16.20 in 1Q 2020)

Is GMO AD Partners Inc. (TYO:4784) A Smart Pick For Income Investors?

What Do The Returns On Capital At GMO AD Partners (TYO:4784) Tell Us?

Does GMO AD Partners' (TYO:4784) Share Price Gain of 58% Match Its Business Performance?

New 90-day low: JP¥557

GMO AD Partners Inc., Annual General Meeting, Mar 21, 2021

Full year 2020 earnings released: EPS JP¥16.20 (vs JP¥14.88 in FY 2019)

Three Things You Should Check Before Buying GMO AD Partners Inc. (TYO:4784) For Its Dividend

Is Weakness In GMO AD Partners Inc. (TYO:4784) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Three Days Left To Buy GMO AD Partners Inc. (TYO:4784) Before The Ex-Dividend Date

Upcoming Dividend of JP¥12.80 Per Share

Should You Be Impressed By GMO AD Partners' (TYO:4784) Returns on Capital?

Should GMO AD Partners (TYO:4784) Be Disappointed With Their 77% Profit?

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: JP¥658

Market bids up stock over the past week

GMO AD Partners Inc. to Report Q3, 2020 Results on Nov 09, 2020

First half earnings released

First half earnings released

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera